Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease
Aliment Pharmacol Ther
.
2019 Oct;50(7):835-836.
doi: 10.1111/apt.15462.
Authors
Teoman Dogru
1
,
Ali Kırık
2
,
Alper Sonmez
3
Affiliations
1
Department of Gastroenterology, Balıkesir University School of Medicine, Balıkesir, Turkey.
2
Department of Internal Medicine, Balıkesir University School of Medicine, Balıkesir, Turkey.
3
Department of Endocrinology and Metabolism, Health Sciences University, Gulhane Medical School, Ankara, Turkey.
PMID:
31532548
DOI:
10.1111/apt.15462
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular*
Diabetes Mellitus*
Humans
Liver Cirrhosis
Liver Neoplasms*
Metformin*
Non-alcoholic Fatty Liver Disease*
Substances
Metformin